From Molecular Classification to Targeted Therapeutics: The Changing Face of Systemic Therapy in Metastatic Gastroesophageal Cancer

por Murphy, Adrian, Kelly, Ronan J.
Publicado 2015

The evolution of cyclodextrin glucanotransferase product specificity

por Kelly, Ronan M., Dijkhuizen, Lubbert, Leemhuis, Hans
Publicado 2009

Engineering of cyclodextrin glucanotransferases and the impact for biotechnological applications

por Leemhuis, Hans, Kelly, Ronan M., Dijkhuizen, Lubbert
Publicado 2009

Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine

por Sharon, Elad, Kelly, Ronan J, Szabo, Eva
Publicado 2010

Role of Immunotherapy in Gastroesophageal Cancers—Advances, Challenges and Future Strategies

por Lynch, Emer, Duffy, Austin G., Kelly, Ronan J.
Publicado 2023

Immune Checkpoint Inhibitors: Changing the Treatment Landscape in Esophagogastric Adenocarcinoma

por Lynch, Emer, Duffy, Austin G., Kelly, Ronan J.
Publicado 2023

A very rare case of incidental aortic valve fibrolipoma

por Karsan, Rickesh Bharat, Kelly, Ronan, Healy, Estelle, Jeganathan, Reuben
Publicado 2021

Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin

por Kelly, Ronan J, Lopez-Chavez, Ariel, Citrin, Deborah, Janik, John E, Morris, John C
Publicado 2011

Mapping the molecular basis for growth related phenotypes in industrial producer CHO cell lines using differential proteomic analysis

por Bryan, Laura, Henry, Michael, Kelly, Ronan M., Frye, Christopher C., Osborne, Matthew D., Clynes, Martin, Meleady, Paula
Publicado 2021

Early experience of aortic surgery during the COVID‐19 pandemic in the UK: A multicentre study

por Lopez‐Marco, Ana, Harky, Amer, Verdichizzo, Danilo, Hope, Emma, Rosser, Barbara, McPherson, Iain, Kelly, Ronan, Holland, Luke, Ye Oo, Aung
Publicado 2021

Differential expression of miRNAs and functional role of mir-200a in high and low productivity CHO cells expressing an Fc fusion protein

por Bryan, Laura, Henry, Michael, Barron, Niall, Gallagher, Clair, Kelly, Ronan M., Frye, Christopher C., Osborne, Matthew D., Clynes, Martin, Meleady, Paula
Publicado 2021

High yield reproducible rat model recapitulating human Barrett’s carcinogenesis

por Matsui, Daisuke, Omstead, Ashten N, Kosovec, Juliann E, Komatsu, Yoshihiro, Lloyd, Emily J, Raphael, Hailey, Kelly, Ronan J, Zaidi, Ali H, Jobe, Blair A
Publicado 2017

Phase Ib/II study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) and tremelimumab as monotherapy or in combination, in patients with recurrent or metastatic...

por Kelly, Ronan J, Chung, Ki, Gu, Yu, Steele, Keith E, Rebelatto, Marlon C, Robbins, Paul B, Tavakkoli, Fatemeh, Karakunnel, Joyson J, Lai, Dominic W, Almhanna, Khaldoun
Publicado 2015

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma

por Matani, Hirsch, Sahu, Divya, Paskewicz, Michael, Gorbunova, Anastasia, Omstead, Ashten N., Wegner, Rodney, Finley, Gene G., Jobe, Blair A., Kelly, Ronan J., Zaidi, Ali H., Goel, Ajay
Publicado 2022

A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer...

por Marrone, Kristen A., Zhou, Xian, Forde, Patrick M., Purtell, Michael, Brahmer, Julie R., Hann, Christine L., Kelly, Ronan J., Coleman, Barbara, Gabrielson, Edward, Rosner, Gary L., Ettinger, David S.
Publicado 2018

CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease

por Kosovec, Juliann E., Zaidi, Ali H., Omstead, Ashten N., Matsui, Daisuke, Biedka, Mark J., Cox, Erin J., Campbell, Patrick T., Biederman, Robert W.W., Kelly, Ronan J., Jobe, Blair A.
Publicado 2017

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma

por Babar, Laila, Kosovec, Juliann E., Jahangiri, Vida, Chowdhury, Nobel, Zheng, Ping, Omstead, Ashten N., Salvitti, Madison S., Smith, Matthew A., Goel, Ajay, Kelly, Ronan J., Jobe, Blair A., Zaidi, Ali H.
Publicado 2019

Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model

por Zaidi, Ali H., Kelly, Ronan J., Gorbunova, Anastasia, Omstead, Ashten N., Salvitti, Madison S., Zheng, Ping, Kosovec, Juliann E., Lee, Soyoung, Ayazi, Shahin, Babar, Laila, Finley, Gene G., Goel, Ajay, Jobe, Blair A.
Publicado 2021

Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:12...

por Kazda, Christof M., Ding, Ying, Kelly, Ronan P., Garhyan, Parag, Shi, Chunxue, Lim, Chay Ngee, Fu, Haoda, Watson, David E., Lewin, Andrew J., Landschulz, William H., Deeg, Mark A., Moller, David E., Hardy, Thomas A.
Publicado 2017

Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma

por Matsui, Daisuke, Zaidi, Ali H., Martin, Samantha A., Omstead, Ashten N., Kosovec, Juliann E., Huleihel, Luai, Saldin, Lindsey T., DiCarlo, Christina, Silverman, Jan F., Hoppo, Toshitaka, Finley, Gene G., Badylak, Stephen F., Kelly, Ronan J., Jobe, Blair A.
Publicado 2016